|
|
Title |
Author / Artist |
Prod Type |
ISBN/ISBN-13
or UPC |
Pub
Date |
Price |
|  | Resistance to Targeted Therapies in Multiple Myeloma 2021 Edition | Ling, Silvia Cw | Paperback | 3030734420 /
9783030734428 | 07/2022 | $151.99 |
|  | Resistance to Targeted Therapies in Multiple Myeloma 2021 Edition | Ling, Silvia Cw | Hardcover | 3030734390 /
9783030734398 | 07/2021 | $151.99 |
|  | Resistance to Targeted Therapies in Lymphomas 2019 Edition | Xavier, Ana C. | Paperback | 3030244261 /
9783030244262 | 09/2020 | $104.49 |
|  | Current Applications for Overcoming Resistance to Targeted Therapies 2019 Edition | Szewczuk, Myron R. | Paperback | 3030214796 /
9783030214791 | 08/2020 | $104.49 |
|  | Cancer Stem Cell Resistance to Targeted Therapy 2019 Edition | Maccalli, Cristina | Paperback | 3030166260 /
9783030166267 | 08/2020 | $104.49 |
|  | Resistance to Targeted Therapies in Lymphomas 2019 Edition (Resistance to Targeted Anti-Cancer Therapeutics) | Xavier, Ana C. | Hardcover | 3030244237 /
9783030244231 | 09/2019 | $104.49 |
|  | Current Applications for Overcoming Resistance to Targeted Therapies 2019 Edition (Resistance to Targeted Anti-Cancer Therapeutics) | Szewczuk, Myron R. | Hardcover | 3030214761 /
9783030214760 | 08/2019 | $104.49 |
|  | Cancer Stem Cell Resistance to Targeted Therapy 2019 Edition (Resistance to Targeted Anti-Cancer Therapeutics) | Maccalli, Cristina | Hardcover | 3030166236 /
9783030166236 | 06/2019 | $104.49 |
|  | Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways Softcover Repri Edition (Resistance to Targeted Anti-Cancer Therapeutics) | Yarden, Yosef | Paperback | 3030098176 /
9783030098179 | 02/2019 | $161.49 |
|  | Resistance of Targeted Therapies Excluding Antibodies for Lymphomas Softcover Repri Edition (Resistance to Targeted Anti-Cancer Therapeutics) | Ferreri, Andrés J. M. | Paperback | 3030091651 /
9783030091651 | 01/2019 | $123.49 |
|  | Resistance to Ibritumomab in Lymphoma Softcover Repri Edition (Resistance to Targeted Anti-Cancer Therapeutics) | Hosono, Makoto | Paperback | 3030086526 /
9783030086527 | 01/2019 | $104.49 |
|  | Trail, Fas Ligand, Tnf and Tlr3 in Cancer Softcover Repri Edition (Resistance to Targeted Anti-Cancer Therapeutics) | Micheau, Olivier | Paperback | 3319860062 /
9783319860060 | 08/2018 | $161.49 |
|  | Resistance to Molecular Therapies for Hepatocellular Carcinoma Softcover Repri Edition (Resistance to Targeted Anti-Cancer Therapeutics) | Villanueva, Augusto | Paperback | 3319858505 /
9783319858500 | 08/2018 | $161.49 |
|  | Resistance to Targeted Therapies Against Adult Brain Cancers Softcover Repri Edition (Resistance to Targeted Anti-Cancer Therapeutics) | Tivnan, Amanda | Paperback | 3319835319 /
9783319835310 | 07/2018 | $161.49 |
|  | Resistance to Targeted Therapies in Breast Cancer Softcover Repri Edition (Resistance to Targeted Anti-Cancer Therapeutics) | Prosperi, Jenifer R. | Paperback | 3319888919 /
9783319888910 | 06/2018 | $113.99 |
|  | Resistance to Ibritumomab in Lymphoma 2018 Edition (Resistance to Targeted Anti-Cancer Therapeutics) | Hosono, Makoto | Hardcover | 3319782371 /
9783319782379 | 05/2018 | $104.49 |
|  | Resistance to Tyrosine Kinase Inhibitors Softcover Repri Edition (Resistance to Targeted Anti-Cancer Therapeutics) | Focosi, Daniele | Paperback | 331983438X /
9783319834382 | 04/2018 | $161.49 |
|  | Defects in T Cell Trafficking and Resistance to Cancer Immunotherapy Softcover Repri Edition (Resistance to Targeted Anti-Cancer Therapeutics) | Donnadieu, Emmanuel | Paperback | 3319825283 /
9783319825281 | 04/2018 | $104.49 |
|  | Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways 2018 Edition (Resistance to Targeted Anti-Cancer Therapeutics) | Yarden, Yosef | Hardcover | 3319679309 /
9783319679303 | 04/2018 | $161.49 |
|  | Resistance of Targeted Therapies Excluding Antibodies for Lymphomas 2018 Edition (Resistance to Targeted Anti-Cancer Therapeutics) | Ferreri, Andrés J. M. | Hardcover | 3319751832 /
9783319751832 | 04/2018 | $123.49 |
|  | Resistance to Targeted Therapies in Breast Cancer 2017 Edition (Resistance to Targeted Anti-Cancer Therapeutics) | Prosperi, Jenifer R. | Hardcover | 331970141X /
9783319701417 | 12/2017 | $161.49 |
|  | Trail, Fas Ligand, Tnf and Tlr3 in Cancer 2017 Edition (Resistance to Targeted Anti-Cancer Therapeutics) | Micheau, Olivier | Hardcover | 3319568043 /
9783319568041 | 07/2017 | $161.49 |
|  | Resistance to Molecular Therapies for Hepatocellular Carcinoma 2017 Edition (Resistance to Targeted Anti-Cancer Therapeutics) | Villanueva, Augusto | Hardcover | 3319561960 /
9783319561967 | 07/2017 | $161.49 |
|  | Resistance to Targeted Therapies Against Adult Brain Cancers (Resistance to Targeted Anti-Cancer Therapeutics) | Tivnan, Amanda | Hardcover | 331946504X /
9783319465043 | 12/2016 | $161.49 |
|  | Resistance to Tyrosine Kinase Inhibitors 2016 Edition (Resistance to Targeted Anti-Cancer Therapeutics) | Focosi, Daniele | Hardcover | 3319460900 /
9783319460901 | 11/2016 | $161.49 |
|
|
|
